Subtitles are available in English and other languages. They are automatically generated using AI, so some errors may occur.
Is DCB a new valid option for coronary revascularisation?
Stents, scaffolds and DCB
Hotline / Late-Breaking Trials
Room 242AB
Anchorperson: Robert Byrne
Spokesperson: Ran Kornowski
Discussants: Michael Joner, Bruno Scheller, Giulio Stefanini, Ron Waksman
Paclitaxel vs sirolimus-coated balloons for CAD: 2-year follow-up of two large registries
Bernardo Cortese
Discussion and audience interaction
Clinical outcomes of bailout stenting after Drug-Coated Balloon angioplasty
Mauro Gitto
Discussion and audience interaction
DEB vs DES for the treatment of large native coronary artery disease: an updated meta-analysis
Jose A. Sorolla Romero
Discussion and audience interaction
Head-to-head comparison of Limus vs Paclitaxel DCBs in the Treatment of In-Stent Restenosis
Marios Sagris
Discussion and audience interaction
Optimal Treatment for Coronary Drug-eluting Stent In-stent Restenosis
Peter Kulyassa
Discussion and audience interaction